On October 17, 2023 OncoNano Medicine, Inc. reported that it will be presenting positive preclinical data detailing delivery of interleukin-12 (IL-12) with the ON-BOARD platform at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper), taking place November 1-5, 2023 in San Diego, California (Press release, OncoNano Medicine, OCT 17, 2023, View Source [SID1234636110]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

ON-BOARD is an ultra pH-sensitive tumor delivery platform designed to minimize systemic exposure and toxicity by protecting oncology intervention payloads and releasing them specifically in the acidic tumor microenvironment. The poster presentation will detail encapsulation and delivery of IL-12, a potent pleiotropic cytokine, using ON-BOARD in immunocompetent mice.

Presentation Overview

TITLE: Encapsulation of IL-12 with an ultra pH-sensitive tumor delivery platform improves tolerability and promotes antitumor response in a preclinical model
PRESENTER: Jason Miller, Ph.D., Associate Director, Research Pipeline Development, OncoNano Medicine
DATE: Friday, November 3, 2023
TIME: 9:00 a.m. – 7:00 p.m. PT
LOCATION: Exhibit Hall B – San Diego Convention Center
POSTER NUMBER: 1147-B